Market Audit for FY 2024–25 (Year ended Dec 31, 2024, published April 29, 2025) Scope & Objective Deloitte Ireland LLP performed...

With discretionary demand slowing down in the first quarter, Tata Consultancy Services (TCS) finds its earlier-stated double-digit growth...

Counted amongst the top 10 largest companies by market, information technology companies Tata Consultancy Services (TCS) and Infosys are...

TCS variable pay: In good news for a majority of its employees, Tata Consultancy Services (TCS), India’s largest IT services firm, will...

Tata Consultancy Services (TCS)’s decision to defer hikes owing to an uncertain business environment and rising costs may have also added...

Here are the FY 2024‑25  details on Reliance Industries’ CSR initiatives: 📝 Board‑Approved CSR Projects for FY 2024‑25 A detailed...

Reliance Industries (RIL), the largest stock in India in terms of market capitalization, is expected to see an exciting period leading up...

Mukesh Ambani-led Reliance Industries Ltd (RIL) plans to consolidate its fast-moving consumer goods (FMCG) brands into a new entity. The...

The Shares of Reliance Industry Up by 25% key reasons are:- 1. Broader analyst base raising price targets Goldman Sachs  added RIL to its...

Domestic brokerage Nuvama Institutional Equities (Nuvama) has raised its target price on oil-to-telecom conglomerate  Reliance Industries...

Dr. Reddy’s Laboratories integrates ESG (Environmental, Social, and Governance) principles  into its business practices through a...

CSR Report Highlights for Dr. Reddy’s FY25: Strategic Focus:  Dr. Reddy’s FY25 Business Responsibility and Sustainability Report (BRSR)...

Dr. Reddy’s Laboratories Financial Report and Auditors’ Report for FY25 Financial Performance (FY25): Revenue:  Dr. Reddy’s reported...

Quality Update At Dr. Reddy’s, we define quality as a ‘pursuit of excellence’, transcending mere compliance, achieved by endorsing a...

Dr. Reddy's continuous efforts to make innovative medicines available to patients in India and emerging markets to meet unmet needs and...

Hyderabad-based pharmaceutical major Dr Reddy’s Laboratories (DRL) has said it is prepared to address an anticipated decline in sales in...

CSR Report for Titan Company FY25 Titan Company’s Corporate Social Responsibility (CSR) activities for FY25 are detailed in its annual...

FY26 Revenue Growth Expectations Titan is targeting double-digit percentage revenue growth in FY26, with a particular focus on the...

Total Income & Revenue Growth Consolidated total income  was ₹57,818 cr, up 22% YoY , crossing the ₹50,000 cr milestone Q4 alone saw...

Q4 FY25 Performance Highlights Consolidated Net Profit: Titan reported a net profit of ₹871 crore in Q4 FY25, marking a strong 13% rise...